0001399529-21-000121.txt : 20210617
0001399529-21-000121.hdr.sgml : 20210617
20210617213702
ACCESSION NUMBER: 0001399529-21-000121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pagan Douglas W.
CENTRAL INDEX KEY: 0001628880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 211026925
MAIL ADDRESS:
STREET 1: 75 KNEELAND STREET
CITY: BOSTON
STATE: MA
ZIP: 02111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205993609
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
wf-form4_162398020794290.xml
FORM 4
X0306
4
2021-06-15
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001628880
Pagan Douglas W.
C/O DICERNA PHARMACEUTICALS, INC.
75 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Common Stock
2021-06-15
4
M
0
6825
A
7764
D
Common Stock
2021-06-15
4
F
0
2004
35.74
D
5760
D
Restricted Stock Units
2021-06-15
4
M
0
6825
0
D
Common Stock
6825.0
20475
D
Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of June 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
/s/ Douglas Fambrough, attorney-in-fact
2021-06-17